UB Paderborn / Katalog / Suche / in CDI

Disturbance–diversity models: what do they really predict and how are they tested?

Proceedings of the Royal Society. B, Biological sciences, 2012-06, Vol.279 (1736), p.2163-2170

2012

Volltextzugriff (PDF)

A Population Pharmacokinetic Model Incorporating Saturable Pharmacokinetics and Autoinduction for High Rifampicin Doses

Clinical pharmacology and therapeutics, 2018-04, Vol.103 (4), p.674-683

2018

Volltextzugriff (PDF)

Efficient and relevant stepwise covariate model building for pharmacometrics

CPT: pharmacometrics and systems pharmacology, 2022-09, Vol.11 (9), p.1210-1222

2022

Volltextzugriff (PDF)

Limiting resources in sessile systems: food enhances diversity and growth of suspension feeders despite available space

Ecology (Durham), 2015-03, Vol.96 (3), p.819-827

2015

Volltextzugriff (PDF)

Combined quantitative tuberculosis biomarker model for time-to-positivity and colony forming unit to support tuberculosis drug development

Frontiers in pharmacology, 2023, Vol.14, p.1067295-1067295

2023

Volltextzugriff (PDF)

Rituximab pharmacokinetic and pharmacokinetic–pharmacodynamic evaluation based on a study in diffuse large B‐cell lymphoma: Influence of tumor size on pharmacokinetic and assessment of pharmacokinetic similarity

CPT: pharmacometrics and systems pharmacology, 2023-02, Vol.12 (2), p.154-167

2023

Volltextzugriff (PDF)

Population repeated time‐to‐event analysis of exacerbations in asthma patients: A novel approach for predicting asthma exacerbations based on biomarkers, spirometry, and diaries/questionnaires

CPT: pharmacometrics and systems pharmacology, 2021-10, Vol.10 (10), p.1221-1235

2021

Volltextzugriff (PDF)

Greater Early Bactericidal Activity at Higher Rifampicin Doses Revealed by Modeling and Clinical Trial Simulations

The Journal of infectious diseases, 2018-08, Vol.218 (6), p.991-999

2018

Volltextzugriff (PDF)

The Potential for Treatment Shortening With Higher Rifampicin Doses: Relating Drug Exposure to Treatment Response in Patients With Pulmonary Tuberculosis

Clinical infectious diseases, 2018-06, Vol.67 (1), p.34-41

2018

Volltextzugriff (PDF)

Rifampicin Can Be Given as Flat-Dosing Instead of Weight-Band Dosing

Clinical infectious diseases, 2020-12, Vol.71 (12), p.3055-3060

2020

Volltextzugriff (PDF)

Novel chemical weapon of an exotic macroalga inhibits recruitment of native competitors in the invaded range

The Journal of ecology, 2013-01, Vol.101 (1), p.140-148

2013

Volltextzugriff (PDF)

Drug Effect of Clofazimine on Persisters Explains an Unexpected Increase in Bacterial Load in Patients

Antimicrobial agents and chemotherapy, 2020-04, Vol.64 (5)

2020

Volltextzugriff (PDF)

Population Pharmacokinetics and Exposure‐Response Relationships of Astegolimab in Patients With Severe Asthma

Journal of clinical pharmacology, 2022-07, Vol.62 (7), p.905-917

2022

Volltextzugriff (PDF)

A 2,000‐Year Record of Eelgrass (Zostera marina L.) Colonization Shows Substantial Gains in Blue Carbon Storage and Nutrient Retention

Global biogeochemical cycles, 2024-03, Vol.38 (3), p.n/a

2024

Volltextzugriff (PDF)

Individualised dosing algorithm and personalised treatment of high‐dose rifampicin for tuberculosis

British journal of clinical pharmacology, 2019-10, Vol.85 (10), p.2341-2350

2019

Volltextzugriff (PDF)

Improved power for TB Phase IIa trials using a model-based pharmacokinetic-pharmacodynamic approach compared with commonly used analysis methods

Journal of antimicrobial chemotherapy, 2017-08, Vol.72 (8), p.2311-2319

2017

Volltextzugriff (PDF)

Forecasting Clinical Dose–Response From Preclinical Studies in Tuberculosis Research: Translational Predictions With Rifampicin

Clinical pharmacology and therapeutics, 2018-12, Vol.104 (6), p.1208-1218

2018

Volltextzugriff (PDF)

Difference in persistent tuberculosis bacteria between in vitro and sputum from patients: implications for translational predictions

Scientific reports, 2020-09, Vol.10 (1), p.15537-15537, Article 15537

2020

Volltextzugriff (PDF)

Model-Based Relationship between the Molecular Bacterial Load Assay and Time to Positivity in Liquid Culture

Antimicrobial agents and chemotherapy, 2019-10, Vol.63 (10)

2019

Volltextzugriff (PDF)

Improving treatment outcome assessment in a mouse tuberculosis model

Scientific reports, 2018-04, Vol.8 (1), p.5714-9, Article 5714

2018

Volltextzugriff (PDF)

Equal rates of disturbance cause different patterns of diversity

Ecology (Durham), 2009-02, Vol.90 (2), p.496-505

2009

Volltextzugriff (PDF)

Maximum Species Richness at Intermediate Frequencies of Disturbance: Consistency among Levels of Productivity

Ecology (Durham), 2007-04, Vol.88 (4), p.830-838

2007

Volltextzugriff (PDF)

Physical and biological disturbances interact differently with productivity: effects on floral and faunal richness

Ecology (Durham), 2010-10, Vol.91 (10), p.3069-3080

2010

Volltextzugriff (PDF)

Testing the Potential for Predictive Modeling and Mapping and Extending Its Use as a Tool for Evaluating Management Scenarios and Economic Valuation in the Baltic Sea (PREHAB)

Ambio, 2014-02, Vol.43 (1), p.82-93

2014

Volltextzugriff (PDF)

Application of the Multistate Tuberculosis Pharmacometric Model in Patients With Rifampicin‐Treated Pulmonary Tuberculosis

CPT: pharmacometrics and systems pharmacology, 2016-05, Vol.5 (5), p.264-273

2016

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Disturbance–diversity models: what do they really predict and how are they tested?

A Population Pharmacokinetic Model Incorporating Saturable Pharmacokinetics and Autoinduction for High Rifampicin Doses

Efficient and relevant stepwise covariate model building for pharmacometrics

Limiting resources in sessile systems: food enhances diversity and growth of suspension feeders despite available space

Combined quantitative tuberculosis biomarker model for time-to-positivity and colony forming unit to support tuberculosis drug development

Rituximab pharmacokinetic and pharmacokinetic–pharmacodynamic evaluation based on a study in diffuse large B‐cell lymphoma: Influence of tumor size on pharmacokinetic and assessment of pharmacokinetic similarity

Population repeated time‐to‐event analysis of exacerbations in asthma patients: A novel approach for predicting asthma exacerbations based on biomarkers, spirometry, and diaries/questionnaires

Greater Early Bactericidal Activity at Higher Rifampicin Doses Revealed by Modeling and Clinical Trial Simulations

The Potential for Treatment Shortening With Higher Rifampicin Doses: Relating Drug Exposure to Treatment Response in Patients With Pulmonary Tuberculosis

Rifampicin Can Be Given as Flat-Dosing Instead of Weight-Band Dosing

Novel chemical weapon of an exotic macroalga inhibits recruitment of native competitors in the invaded range

Drug Effect of Clofazimine on Persisters Explains an Unexpected Increase in Bacterial Load in Patients

Population Pharmacokinetics and Exposure‐Response Relationships of Astegolimab in Patients With Severe Asthma

A 2,000‐Year Record of Eelgrass (Zostera marina L.) Colonization Shows Substantial Gains in Blue Carbon Storage and Nutrient Retention

Individualised dosing algorithm and personalised treatment of high‐dose rifampicin for tuberculosis

Improved power for TB Phase IIa trials using a model-based pharmacokinetic-pharmacodynamic approach compared with commonly used analysis methods

Forecasting Clinical Dose–Response From Preclinical Studies in Tuberculosis Research: Translational Predictions With Rifampicin

Difference in persistent tuberculosis bacteria between in vitro and sputum from patients: implications for translational predictions

Model-Based Relationship between the Molecular Bacterial Load Assay and Time to Positivity in Liquid Culture

Improving treatment outcome assessment in a mouse tuberculosis model

Equal rates of disturbance cause different patterns of diversity

Maximum Species Richness at Intermediate Frequencies of Disturbance: Consistency among Levels of Productivity

Physical and biological disturbances interact differently with productivity: effects on floral and faunal richness

Testing the Potential for Predictive Modeling and Mapping and Extending Its Use as a Tool for Evaluating Management Scenarios and Economic Valuation in the Baltic Sea (PREHAB)

Application of the Multistate Tuberculosis Pharmacometric Model in Patients With Rifampicin‐Treated Pulmonary Tuberculosis

Suchergebnisse filtern